SCHEMBL5457870

SCHEMBL5457870

COc1ccc(Cl)cc1NC(=O)Nc1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 3/20 0.58
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
NAMPT P43490 1/20 0.52
MAPT P10636 7/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
TSHR P16473 1/20 0.52
HTR1A P08908 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
HTR6 P50406 1/20 0.52
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ALK Q9UM73 2/20 0.49
HPGD P15428 2/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458239 0.90 MAPT (0.52) RBP4MEN1KMT2ANAMPTMAPT
SCHEMBL5455872 0.89 MAPT (0.56) MEN1KMT2ANAMPTMAPTSMN1; SMN2
SCHEMBL5470937 0.89 MAPT (0.53) MEN1KMT2ANAMPTMAPTSMN1; SMN2
SCHEMBL5467284 0.88 MAPT (0.56) MEN1KMT2ANAMPTMAPTSMN1; SMN2
SCHEMBL5460919 0.88 NAMPT (0.53) RBP4MEN1KMT2ANAMPTMAPT
SCHEMBL5457926 0.87 MAPT (0.56) MEN1KMT2ANAMPTMAPTSMN1; SMN2
SCHEMBL5460766 0.87 RBP4 (0.67) RBP4MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5460059 0.86 MAPT (0.50) RBP4MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5460804 0.86 MAPT (0.68) MEN1KMT2ANAMPTMAPTSMN1; SMN2
SCHEMBL5465547 0.86 MAPT (0.53) MEN1KMT2ANAMPTMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RBP4 2001/4885MEN1 1828/4885KMT2A 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.